1. Home
  2. XLO vs NDLS Comparison

XLO vs NDLS Comparison

Compare XLO & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • NDLS
  • Stock Information
  • Founded
  • XLO 2016
  • NDLS 1995
  • Country
  • XLO United States
  • NDLS United States
  • Employees
  • XLO N/A
  • NDLS N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • XLO Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • XLO 36.7M
  • NDLS 40.3M
  • IPO Year
  • XLO 2021
  • NDLS 2013
  • Fundamental
  • Price
  • XLO $0.83
  • NDLS $0.98
  • Analyst Decision
  • XLO Buy
  • NDLS Strong Buy
  • Analyst Count
  • XLO 1
  • NDLS 2
  • Target Price
  • XLO $4.00
  • NDLS $3.00
  • AVG Volume (30 Days)
  • XLO 214.3K
  • NDLS 84.8K
  • Earning Date
  • XLO 05-13-2025
  • NDLS 05-07-2025
  • Dividend Yield
  • XLO N/A
  • NDLS N/A
  • EPS Growth
  • XLO N/A
  • NDLS N/A
  • EPS
  • XLO N/A
  • NDLS N/A
  • Revenue
  • XLO $6,344,000.00
  • NDLS $493,271,000.00
  • Revenue This Year
  • XLO $668.96
  • NDLS $4.57
  • Revenue Next Year
  • XLO $14.49
  • NDLS $1.29
  • P/E Ratio
  • XLO N/A
  • NDLS N/A
  • Revenue Growth
  • XLO N/A
  • NDLS N/A
  • 52 Week Low
  • XLO $0.62
  • NDLS $0.55
  • 52 Week High
  • XLO $1.70
  • NDLS $2.36
  • Technical
  • Relative Strength Index (RSI)
  • XLO 58.15
  • NDLS 46.30
  • Support Level
  • XLO $0.79
  • NDLS $0.87
  • Resistance Level
  • XLO $0.85
  • NDLS $0.96
  • Average True Range (ATR)
  • XLO 0.06
  • NDLS 0.09
  • MACD
  • XLO 0.02
  • NDLS 0.01
  • Stochastic Oscillator
  • XLO 86.87
  • NDLS 59.78

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: